Concurrent loss of the Y chromosome in cancer and T cells impacts outcome
Xingyu Chen(Cedars-Sinai Medical Center), Dan Theodorescu(University of Arizona), Martina Tufano(Cedars-Sinai Medical Center), Ekaterina K. Koltsova(Cedars-Sinai Medical Center), Vinícius F. Calsavara(Cedars-Sinai Medical Center), Saravana Kumar Kailasam Mani(Cedars-Sinai Medical Center), Yiling Shen(Cedars-Sinai Medical Center), Lena Hoelzen(Cedars-Sinai Medical Center), Maryam Ranjpour(Cedars-Sinai Medical Center), Mukta Basu(Cedars-Sinai Medical Center), Hany Abdel-Hafiz(University of Arizona), Su Hyun Choi(Korea Institute of Industrial Technology), Jia Zhu(Cedars-Sinai Medical Center), Simon Knott(Cedars-Sinai Medical Center), V. Krishnan Ramanujan(Cedars-Sinai Medical Center)
Cited by 26
Related Papers
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
|Science Translational Medicine|2014|5.1k
<i>TERT</i> promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal
|Proceedings of the National Academy of Sciences|2013|1.4k
Advances in bladder cancer biology and therapy
|Nature reviews. Cancer|2020|783
Naturally Occurring Human Urinary Peptides for Use in Diagnosis of Chronic Kidney Disease
|Molecular & Cellular Proteomics|2010|537
Recommendations for Biomarker Identification and Qualification in Clinical Proteomics
|Science Translational Medicine|2010|335